Revealed: 1 Marijuana Stock I Like More Than Aurora Cannabis (TSX:ACB)

Fire & Flower Holdings Inc. (TSXV:FAF) is one cannabis penny stock that could make you filthy rich.

| More on:
Powder of Cannabis (Drugs), Analysis of Cannabis in laboratory.

Image source: Getty Images

You’re reading a free article with opinions that may differ from The Motley Fool’s premium investing services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn moresdf

In prior pieces, I’ve highlighted several reasons why Aurora Cannabis was one of my preferred picks in the highly speculative marijuana market. Aurora was growing tonnes of weed in a somewhat efficient manner, which is how a firm can succeed in a commoditized market.

Although you could make a quick buck from betting on cannabis cultivators, I’d much prefer owning shares of a company that’s able to differentiate itself in some form or another. As a grower and distributor of weed, there isn’t much wiggle room to promote brand differentiation with all the regulations that are in place.

Aurora Cannabis and many other pot firms have hovered in the grey area in the past with the hopes of making a name for themselves through the promotion of music festivals. As Health Canada cracks down on the rule breakers, however, every firm’s compliance will be heightened, making it nearly impossible to garner brand loyalty.

How can a cannabis company differentiate itself with all that red tape?

It’s simple: don’t be a cannabis producer, and you won’t be subject to the regulations that seek to make product differentiation next to impossible.

Fire & Flower Holdings (TSXV:FAF), an Edmonton-based cannabis retailer, recently caught my attention after Alimentation Couche-Tard announced its 9.9% stake in the company with the option to own a controlling stake in the firm should it choose to.

Fire & Flower is a marijuana penny stock with a market cap of just $160 million. Shares trade for $1.35, and although I’ve urged Foolish investors to avoid penny stocks like the plague, I think Fire & Flower is a rare exception. It’s a legitimate play that likely has a risk/reward trade-off that favours the investor.

The cannabis retailer has only 23 cannabis shops across the prairies and Ontario. Although it’s tough to trust the management team of a firm that’s as small as Fire & Flower, I am encouraged by all the good things that CEO Brian Hannasch had to say about the management and its expertise in physical and digital cannabis retail.

Moreover, one can’t help but notice how gorgeous the Fire & Flower store layout is. It’s like the Apple store of weed. And although such an arrangement can easily be replicated by some other micro-cap up-and-comer, I think Fire & Flower can keep competitors at bay thanks to the involvement of Couche-Tard and its deep pockets, which will help the company scale up faster than its less-capitalized peers.

Couche-Tard has a brilliant management team that’s been delivering market-crushing results for investors over the years. They’re prudent when it comes to M&A, and it’s going to be no different with Couche-Tard’s initial investment in the world of cannabis.

Hannasch and company clearly see something in Fire & Flower, and it’s not hard to see why. The company has a robust online presence and ample room for an ambitious national expansion. Although Couche-Tard’s initial investment is just a toe in the waters, I think Fire & Flower may be scooped up entirely in a few years’ time should things go smoothly.

In any case, Fire & Flower is a sound investment — not a speculation, despite being in deep penny-stock territory.

This article represents the opinion of the writer, who may disagree with the “official” recommendation position of a Motley Fool premium service or advisor. We’re Motley! Questioning an investing thesis — even one of our own — helps us all think critically about investing and make decisions that help us become smarter, happier, and richer, so we sometimes publish articles that may not be in line with recommendations, rankings or other content.

Fool contributor Joey Frenette owns shares of ALIMENTATION COUCHE-TARD INC and Apple. David Gardner owns shares of Apple. The Motley Fool owns shares of Apple and has the following options: short January 2020 $155 calls on Apple, long January 2020 $150 calls on Apple, short January 2020 $155 calls on Apple, and long January 2020 $150 calls on Apple. Couche-Tard is a recommendation of Stock Advisor Canada.

More on Cannabis Stocks

Cannabis smoke
Cannabis Stocks

Canopy Growth Stock: Is Now a Good Time to Invest?

The road ahead is highly uncertain for Canopy Growth, as the stock is plagued with losses and seemingly unsurmountable industry…

Read more »

Cannabis grows at a commercial farm.
Cannabis Stocks

TLRY Stock: Should You Invest Now?

TLRY is a Canadian cannabis stock which is trading 91% below record highs. Let's see if you should own TLRY…

Read more »

Cannabis grows at a commercial farm.
Cannabis Stocks

Is Tilray Stock a Buy in February 2023?

Despite the volatile cannabis sector, Tilray could be a superb buy for long-term investors.

Read more »

Young woman sat at laptop by a window
Cannabis Stocks

Is SNDL Stock a Buy in February 2023?

SNDL is a beaten-down cannabis stock. While its revenue growth is exceptional, a weak balance sheet has driven stock prices…

Read more »

A cannabis plant grows.
Cannabis Stocks

TLRY Stock: Here’s What’s Coming in 2023

Tilray Inc. (TSX:TLRY) is geared up for big growth this decade and looks like one of the top cannabis stocks…

Read more »

A person holds a small glass jar of marijuana.
Cannabis Stocks

Canopy Growth Stock: Here’s What’s Coming in 2023

Canopy Growth stock has made a lot of new moves in the last few months, but where is the company…

Read more »

A cannabis plant grows.
Cannabis Stocks

Better Cannabis Buy: Canopy Growth Stock or Tilray?

Only two TSX weed stocks can deliver substantial returns in the highly anticipated growth of the global cannabis market.

Read more »

Medicinal research is conducted on cannabis.
Cannabis Stocks

Is Tilray Stock a Buy in January 2023?

Tilray stock has lost 50% of its value in the last 12 months, in line with its peers.

Read more »